U-Blot® Research Grade IchorcumabCat. No. WA2956$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade IchorcumabCat. No. WA2956
U-Blot® Research Grade IbritumomabCat. No. WA2955
U-Blot® Research Grade ibramvibartCat. No. WA2954
U-Blot® Research Grade IbentatugCat. No. WA2953
U-Blot® Research Grade IbalizumabCat. No. WA2952
U-Blot® Research Grade IanalumabCat. No. WA2951
U-Blot® Research Grade HuMax-IL8Cat. No. WA2950
U-Blot® Research Grade HuMax-IL15Cat. No. WA2949
U-Blot® Research Grade HuJ591-GsmabCat. No. WA2948
U-Blot® Research Grade HuCC49Cat. No. WA2947
U-Blot® Research Grade HKT288Cat. No. WA2946
U-Blot® Research Grade HersintuzumabCat. No. WA2945